S&P 500   3,830.18 (-0.29%)
DOW   30,808.59 (-0.61%)
QQQ   326.79 (+0.42%)
AAPL   142.77 (+2.66%)
MSFT   227.09 (+0.50%)
FB   275.43 (+0.34%)
GOOGL   1,878.66 (-0.73%)
AMZN   3,294.66 (+0.07%)
TSLA   872.27 (+3.03%)
NVDA   541.06 (-1.36%)
BABA   261.50 (+1.11%)
CGC   33.22 (-1.72%)
GE   10.96 (-1.35%)
MU   80.45 (-2.22%)
AMD   93.51 (+0.78%)
NIO   60.29 (-2.68%)
T   28.87 (-0.21%)
F   11.08 (-3.82%)
ACB   10.34 (-2.91%)
BA   201.15 (-2.28%)
DIS   170.28 (-1.45%)
NFLX   558.42 (-1.19%)
GILD   66.64 (-0.45%)
S&P 500   3,830.18 (-0.29%)
DOW   30,808.59 (-0.61%)
QQQ   326.79 (+0.42%)
AAPL   142.77 (+2.66%)
MSFT   227.09 (+0.50%)
FB   275.43 (+0.34%)
GOOGL   1,878.66 (-0.73%)
AMZN   3,294.66 (+0.07%)
TSLA   872.27 (+3.03%)
NVDA   541.06 (-1.36%)
BABA   261.50 (+1.11%)
CGC   33.22 (-1.72%)
GE   10.96 (-1.35%)
MU   80.45 (-2.22%)
AMD   93.51 (+0.78%)
NIO   60.29 (-2.68%)
T   28.87 (-0.21%)
F   11.08 (-3.82%)
ACB   10.34 (-2.91%)
BA   201.15 (-2.28%)
DIS   170.28 (-1.45%)
NFLX   558.42 (-1.19%)
GILD   66.64 (-0.45%)
S&P 500   3,830.18 (-0.29%)
DOW   30,808.59 (-0.61%)
QQQ   326.79 (+0.42%)
AAPL   142.77 (+2.66%)
MSFT   227.09 (+0.50%)
FB   275.43 (+0.34%)
GOOGL   1,878.66 (-0.73%)
AMZN   3,294.66 (+0.07%)
TSLA   872.27 (+3.03%)
NVDA   541.06 (-1.36%)
BABA   261.50 (+1.11%)
CGC   33.22 (-1.72%)
GE   10.96 (-1.35%)
MU   80.45 (-2.22%)
AMD   93.51 (+0.78%)
NIO   60.29 (-2.68%)
T   28.87 (-0.21%)
F   11.08 (-3.82%)
ACB   10.34 (-2.91%)
BA   201.15 (-2.28%)
DIS   170.28 (-1.45%)
NFLX   558.42 (-1.19%)
GILD   66.64 (-0.45%)
S&P 500   3,830.18 (-0.29%)
DOW   30,808.59 (-0.61%)
QQQ   326.79 (+0.42%)
AAPL   142.77 (+2.66%)
MSFT   227.09 (+0.50%)
FB   275.43 (+0.34%)
GOOGL   1,878.66 (-0.73%)
AMZN   3,294.66 (+0.07%)
TSLA   872.27 (+3.03%)
NVDA   541.06 (-1.36%)
BABA   261.50 (+1.11%)
CGC   33.22 (-1.72%)
GE   10.96 (-1.35%)
MU   80.45 (-2.22%)
AMD   93.51 (+0.78%)
NIO   60.29 (-2.68%)
T   28.87 (-0.21%)
F   11.08 (-3.82%)
ACB   10.34 (-2.91%)
BA   201.15 (-2.28%)
DIS   170.28 (-1.45%)
NFLX   558.42 (-1.19%)
GILD   66.64 (-0.45%)
Log in
OTCMKTS:ETST

Earth Science Tech Stock Forecast, Price & News

$0.05
0.00 (-5.26 %)
(As of 01/22/2021 08:28 PM ET)
Add
Compare
Today's Range
$0.04
Now: $0.05
$0.05
50-Day Range
$0.01
MA: $0.02
$0.05
52-Week Range
$0.01
Now: $0.05
$0.14
Volume281,300 shs
Average Volume412,500 shs
Market Capitalization$2.07 million
P/E RatioN/A
Dividend YieldN/A
Beta2.53
Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focuses on delivering nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, and aging. Its products include vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company markets its products in a range of formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs. It also offers Cannabidiol oil to retailers in the vaping industry; and cannabinoid products. In addition, the company retails health, wellness, sports nutrition, and dietary supplement products. Earth Science Tech, Inc. offers its products through its retail store located in Coral Gables, Florida, as well as through the internet. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in April 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Doral, Florida.

MarketRank

Overall MarketRank

0.52 out of 5 stars

Medical Sector

1458th out of 1,923 stocks

Pharmaceutical Preparations Industry

634th out of 773 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ETST
CUSIPN/A
CIKN/A
Phone305-615-2118
Employees6
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$530,000.00
Book Value($0.02) per share

Profitability

Net Income$-1,200,000.00
Net Margins-1,750.31%

Miscellaneous

Market Cap$2.07 million
Next Earnings DateN/A
OptionableNot Optionable
$0.05
0.00 (-5.26 %)
(As of 01/22/2021 08:28 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ETST News and Ratings via Email

Sign-up to receive the latest news and ratings for ETST and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Earth Science Tech (OTCMKTS:ETST) Frequently Asked Questions

How has Earth Science Tech's stock price been impacted by COVID-19 (Coronavirus)?

Earth Science Tech's stock was trading at $0.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ETST stock has decreased by 10.0% and is now trading at $0.0450.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Earth Science Tech?

Wall Street analysts have given Earth Science Tech a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Earth Science Tech wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Earth Science Tech?

Earth Science Tech saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 35,900 shares, an increase of 955.9% from the December 15th total of 3,400 shares. Based on an average trading volume of 534,000 shares, the short-interest ratio is presently 0.1 days.
View Earth Science Tech's Short Interest
.

Who are some of Earth Science Tech's key competitors?

What other stocks do shareholders of Earth Science Tech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Earth Science Tech investors own include HEXO Corp. (HEXO.TO) (HEXO), Sugarmade (SGMD) and Arch Therapeutics (ARTH).

Who are Earth Science Tech's key executives?

Earth Science Tech's management team includes the following people:
  • Mr. Nickolas Salomon Tabraue, Chairman, CEO, Pres & Sec. (Age 33, Pay $84k)
  • Mr. Wendell Hecker, Chief Financial Officer (Age 65, Pay $28.3k)
  • Mr. Gregg Gagan Hunter, COO & Director (Age 62, Pay $72k)
  • Mr. Steven Warm J.D., Esq., Chief Legal Counsel & Director (Age 78)
  • Mr. Sergio Castillo, Chief Marketing Officer (Age 37)
  • Mr. David Barbash, Chief Sales Officer (Age 55)
  • Mr. Jad Nammour, Chief of Pharmacy
  • Ms. Erika Franck, Head of New Sales Division
  • Mr. Robert Stevens, Court-Appointed Receiver (Age 55)

What is Earth Science Tech's stock symbol?

Earth Science Tech trades on the OTCMKTS under the ticker symbol "ETST."

How do I buy shares of Earth Science Tech?

Shares of ETST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Earth Science Tech's stock price today?

One share of ETST stock can currently be purchased for approximately $0.05.

How big of a company is Earth Science Tech?

Earth Science Tech has a market capitalization of $2.07 million and generates $530,000.00 in revenue each year. Earth Science Tech employs 6 workers across the globe.

What is Earth Science Tech's official website?

The official website for Earth Science Tech is www.earthsciencetech.com.

How can I contact Earth Science Tech?

Earth Science Tech's mailing address is 8000 NW 31STH STREET UNIT 19, DORAL FL, 33122. The company can be reached via phone at 305-615-2118.

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.